Global Research Accelerates on GLP-1 Drugs: Ozempic and Classmates Show Promise in Reshaping the Brain, Slowing Aging, Easing Knee Osteoarthritis, Reducing Cancer Risks, and MoreNew Delhi, June 4, 2026: In the span of just a few years, GLP-1 receptor agonists — the class of medications that includes semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — have evolved from diabetes and obesity treatments into one of medicine&rsquo......View Details
Global Research Accelerates on GLP-1 Drugs: Ozempic and Classmates Show Promise in Reshaping the Brain, Slowing Aging, Easing Knee Osteoarthritis, Reducing Cancer Risks, and More
New Delhi, June 4, 2026: In the span of just a few years, GLP-1 receptor agonists — the class of medications that includes semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — have evolved from diabetes and obesity treatments into one of medicine&rsquo......
View Details
